… sustained superiority over sunitinib monotherapy (Sutent) in patients with previously … among the various trials comparing these types of drug combinations,” said  … trial data for advanced kidney cancer treatment. News release. Vanderbilt University Medical …

… impose tariffs on imported drugs. These tariffs are … that specializes in pharmaceuticals, biotechnology, and medical devices. With a … IVL) platform for the treatment of coronary artery disease … under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, …

… in the Department of Medical Oncology & … guidelines for second-line treatments, while emphasizing the … , pazopanib [Votrient], sunitinib [Sutent], bevacizumab [Avastin], etc, … pharmacology and drug-drug interactions of anti-angiogenic drugs. Cancer …

… features, biologies, and treatment responses. nccRCC histologies include … excluded from RCC clinical trials, which mainly enrolled … led investigator-initiated randomized trial, patients with untreated … TKI) monotherapy with sunitinib (Sutent). The study met its …

… Sarcoma Unit and a medical oncologist at The Royal … , randomized phase 3 IMADGIST trial. IMADGIST evaluated maintenance imatinib … 2 randomized trials which will hopefully guide treatment in the … receive ripretinib or sunitinib [Sutent]. The primary end point …

… care while on clinical trials because we are actively … tolerability, effectiveness of the drugs, and how long patients … effects, hold the medication, and then resume treatment. As for tumor … Sutent (sunitinib). This is the STELLAR-304 study, a large trial …

… a consultant medical oncologist, professor of medical oncology, and … in the evolving treatment landscape for patients with … recently completed trials. The phase 3 INSIGHT trial (NCT05734105) … (Qinlock) or sunitinib (Sutent), with progression-free survival …

… sustained clinical benefit vs sunitinib (Sutent) in patients with advanced … among the various trials comparing these types of drug combinations,” Brian Rini … clinical trial data for advanced kidney cancer treatment. News release. Vanderbilt University Medical …

… ;s sustained superiority over sunitinib (Sutent) monotherapy, reinforcing its role as … foundation for future, more personalized treatment strategies. One notable finding was … reports final clinical trial data for advanced kidney cancer treatment. VUMC News …

… director of Clinical Trials, Breast Oncology; and … professor of medicine at Harvard Medical School, previously … drug conjugates, and targeted therapies, we are not only providing better treatments … ;ipilimumab vs sunitinib (Sutent). However, clinical outcomes …